Unknown

Dataset Information

0

Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.


ABSTRACT: Circulating tumor cells (CTCs) provide a readily accessible source of tumor material from patients with cancer. Molecular profiling of these rare cells can lead to insight on disease progression and therapeutic strategies. A critical need exists to isolate CTCs with sufficient quantity and sample integrity to adapt to conventional analytical techniques. We present a microfluidic platform (IsoFlux) that uses flow control and immunomagnetic capture to enhance CTC isolation. A novel cell retrieval mechanism ensures complete transfer of CTCs into the molecular assay. Improved sensitivity to the capture antigen was demonstrated by spike-in experiments for three cell lines of varying levels of antigen expression. We obtained spike-in recovery rates of 74%, 75%, and 85% for MDA-MB-231 (low), PC3 (middle), and SKBR3 (high) cell lines. Recovery using matched enumeration protocols and matched samples (PC3) yielded 90% and 40% recovery for the IsoFlux and CellSearch systems, respectively. In matched prostate cancer samples (N = 22), patients presenting more than four CTCs per blood draw were 95% and 36% using IsoFlux and CellSearch, respectively. An assay for detecting KRAS mutations was described along with data from patients with colorectal cancer, of which 87% presented CTCs above the assay's limit of detection (four CTCs). The CTC KRAS mutant rate was 50%, with 46% of patients displaying a CTC KRAS mutational status that differed from the previously acquired tissue biopsy data. The microfluidic system and mutation assay presented here provide a complete workflow to track oncogene mutational changes longitudinally with high success rates.

SUBMITTER: Harb W 

PROVIDER: S-EPMC3799195 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.

Harb Wael W   Fan Andrea A   Tran Tony T   Danila Daniel C DC   Keys David D   Schwartz Michael M   Ionescu-Zanetti Cristian C  

Translational oncology 20131001 5


Circulating tumor cells (CTCs) provide a readily accessible source of tumor material from patients with cancer. Molecular profiling of these rare cells can lead to insight on disease progression and therapeutic strategies. A critical need exists to isolate CTCs with sufficient quantity and sample integrity to adapt to conventional analytical techniques. We present a microfluidic platform (IsoFlux) that uses flow control and immunomagnetic capture to enhance CTC isolation. A novel cell retrieval  ...[more]

Similar Datasets

| S-EPMC3364832 | biostudies-other
2015-05-17 | E-GEOD-67939 | biostudies-arrayexpress
2015-05-17 | GSE67939 | GEO
| S-EPMC6406949 | biostudies-literature
| S-EPMC2923460 | biostudies-literature
2015-07-21 | GSE65516 | GEO
| S-EPMC7281227 | biostudies-literature
| S-EPMC6951813 | biostudies-literature
| S-EPMC4490017 | biostudies-literature
| S-EPMC3338784 | biostudies-literature